Double Phase Clinical Trial to Investigate Prevalence of Neuropathic Pain in Gynecologic Cancer Patients and Efficacy and Safety of Opioids on Pain Management among the Same Populatio
Not Applicable
- Conditions
- Gynecologic malignancies
- Registration Number
- JPRN-UMIN000013725
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients hypersensitive to opium alkaloids 2. Patients with serious depressed respiration or serious chronic obstructive lung disease (refer to contraindication) 3. Patients received surgery, chemotherapy or palliative radiotherapy within 2 weeks affected pain assessment, or scheduled these therapies during study period 4. Patients with severely impaired hepatic or renal function 5. Patients pregnant or possibly pregnant 6. Patients with cancer treatment related pain solely 7. Patients judged unsuitable for study subject by responsible physicians due to other clinical reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Patient demographics 2.Pain related 3.QOL related 4.Adverse events 5.Laboratory data 6.Imaging
- Secondary Outcome Measures
Name Time Method